Met Life Investment Management, LLC Seagen Inc. Transaction History

Met Life Investment Management, LLC

$14.7 Billion
Q1 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 09, 2024	BUY	$191.51 - $216.16 $72,390 - $81,708	378 Added 4.59%	8,617 $1.83 Million
Q3 2023 Apr 29, 2024	BUY	$191.51 - $216.16 $766 - $864	4 Added 0.05%	8,617 $1.83 Million
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $766 - $864	4 Added 0.05%	8,617 $1.83 Million
Q2 2023 Apr 29, 2024	BUY	$187.64 - $206.25 $1.62 Million - $1.78 Million	8,613 New	8,613 $1.66 Million
Q2 2023 Aug 10, 2023	BUY	$187.64 - $206.25 $70,177 - $77,137	374 Added 4.54%	8,613 $1.66 Million

Q1 2023 May 09, 2024	BUY	$127.59 - $203.08 $1.05 Million - $1.67 Million	8,239 New	8,239 $1.67 Billion
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $2,551 - $4,061	20 Added 0.24%	8,239 $1.67 Million
Q4 2022 May 10, 2024	SELL	$117.37 - $139.17 $25,469 - $30,199	-217 Reduced 2.57%	8,219 $1.06 Million
Q4 2022 Jun 14, 2023	SELL	$117.37 - $139.17 $2,347 - $2,783	-20 Reduced 0.24%	8,219 $1.06 Million
Q4 2022 Mar 22, 2023	SELL	$117.37 - $139.17 $25,469 - $30,199	-217 Reduced 2.57%	8,219 $1.06 Million
Q4 2022 Feb 15, 2023	SELL	$117.37 - $139.17 $25,469 - $30,199	-217 Reduced 2.57%	8,219 $1.06 Million
Q3 2022 May 10, 2024	BUY	$135.27 - $180.11 $811 - $1,080	6 Added 0.07%	8,436 $1.15 Million
Q3 2022 Jun 14, 2023	BUY	$135.27 - $180.11 $26,648 - $35,481	197 Added 2.39%	8,436 $1.15 Million
Q3 2022 Mar 22, 2023	BUY	$135.27 - $180.11 $811 - $1,080	6 Added 0.07%	8,436 $1.15 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $811 - $1,080	6 Added 0.07%	8,436 $1.15 Million
Q2 2022 May 10, 2024	BUY	$108.81 - $179.33 $36,886 - $60,792	339 Added 4.19%	8,430 $1.49 Million
Q2 2022 Jun 20, 2023	BUY	$108.81 - $179.33 $20,782 - $34,252	191 Added 2.32%	8,430 $1.49 Million
Q2 2022 Mar 22, 2023	BUY	$108.81 - $179.33 $36,886 - $60,792	339 Added 4.19%	8,430 $1.49 Million
Q2 2022 Aug 11, 2022	BUY	$108.81 - $179.33 $36,886 - $60,792	339 Added 4.19%	8,430 $1.49 Million
Q1 2022 May 10, 2024	BUY	$119.61 - $157.85 $967,764 - $1.28 Million	8,091 New	8,091 $1.17 Million
Q1 2022 Jun 20, 2023	SELL	$119.61 - $157.85 $17,702 - $23,361	-148 Reduced 1.8%	8,091 $1.17 Million
Q1 2022 Mar 22, 2023	BUY	$119.61 - $157.85 $933,795 - $1.23 Million	7,807 Added 2748.94%	8,091 $1.17 Million
Q1 2022 May 12, 2022	BUY	$119.61 - $157.85 $967,764 - $1.28 Million	8,091 New	8,091 $1.17 Million
Q4 2021 Feb 15, 2022	SELL	$142.57 - $190.86 $40,489 - $54,204	-284 Closed	0 $0
Q3 2021 Mar 22, 2023	SELL	$142.45 - $169.82 $1.13 Million - $1.35 Million	-7,935 Reduced 96.54%	284 $48,000
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $40,455 - $48,228	284 New	284 $48,000

Others Institutions Holding SGEN

# of Institutions

Shares Held

1.26M

Call Options Held

23K

Put Options Held

55.2K

View Full List

About Seagen Inc.

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

More about SGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account